Clinical Trial Details
Braintumor Website

[Information provided by: ClinicalTrials.gov, which provides patients, family members, and members of the public easy and free access to information on clinical studies for a wide range of diseases and conditions.]

NCT02131688 : Phase I Study of Mitoxantrone Hydrochloride Liposome Injection
PhasePhase 1
AgesMin: 18 Years Max: 70 Years
Eligibility
Inclusion Criteria:

- Patients must compliance with the requirements and restrictions listed in the consent
form

- Patients with Pathology and / or cytologically proven malignant lymphoma

- Patients must be 18-70 years old ,both male and female

- Failure of standard chemotherapy

- Patients have no better choice and may be benefit from the use of anthracyclines

- Patients with Eastern Cooperative Oncology Group (ECOG)Performance Status of 0-2

- Objective tumor from the last chemotherapy, biological therapy or other experimental
interval treatment least 4 weeks

- Expected survival time ? 3 months

- Patients agreed to take effective contraceptive measures during the trial

- Blood routine, liver and kidney function, cardiac function examination in accordance
with the following requirements.

Exclusion Criteria:

- Pregnancy and breast-feeding women

- Multiple sclerosis

- Patients that have histories of ischemic heart disease and heart
congestive,arrhythmia that need to be a treatment and significant valvular disease

- Patients with heart disease induced by anthracycline

- Patients requiring other antineoplastic treatment

- Patients with temperature above 38 degrees or active infection that may effects in
clinical tests

- Patients are allergic to anthracycline and liposomal drugs

- Patients are allergic to eggs,egg products,soybean and soybean products

- Patients with uncontrolled primary or metastatic brain tumorsMultiple sclerosis

- Patients that have histories of ischemic heart disease and heart
congestive,arrhythmia that need to be a treatment and significant valvular disease

- Patients with heart disease induced by anthracycline

- Patients requiring other antineoplastic treatment

- Patients with temperature above 38 degrees or active infection that may effects in
clinical tests

- Patients are allergic to anthracycline and liposomal drugs

- Patients are allergic to eggs,egg products,soybean and soybean products

- Patients with uncontrolled primary or metastatic brain tumors

- Total amount of Doxorubicin(or Pirarubicin)?360mg/m2,Epirubicin ?600mg/m2
LinksPermanent Link to THIS page: https://virtualtrials.com/nct/display1trial.cfm?nct=NCT02131688      |      Link to official Clinicaltrials.gov listing
Locations



Home | Brain Tumor Guide | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Novocure Optune® | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us

Copyright (c) 1993 - 2019 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557
888-295-4740